Title: Diagnostic and Prognostic Significance of Prostate Specific Antigens (PSA), in Patients Suffering from Carcinoma Prostate, Attending in N.M.C.H., Patna

Authors: Dr C.P. Jaiswal, Dr Sunil Kumar, Dr Satyendu Sagar

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i11.117

Abstract

Objective: The aim of Present study was undertaken to evaluate the level of prostate - specific antigen (PSA) in patients suffering from carcinoma Prostate along with their Histopathological correlations.

Materials and Methods: A total of 250 male patients, of different age groups, presents with various urological complains, attending in medical and surgical OPD were included in the study. All the demographic data were noted. After the diagnosis by PSA, 90 cases were operated and send for histopathological examination in our department. PSA evaluation was done by Chemiluminescens immunoassay (CLIA) methods by fully automated machine supplied by Roche pharma.

All data regarding routine tests (CBC, LFT, KFT, TSH, Blood sugar, USG Lower abdomen) were recorded.

Result: Out of 250 patients, 36.8% patients were in 61-75 years of age, followed by 34.4% in 51-60 years of age. 33.64% patients had benign prostatic hypertrophy (BPH) followed by 22.40% patients had prostatitis. 19.2% had suspected cases of Ca prostate. 23.06% patients were suffers from Ca prostate with nodal involvement and 1.2% patients had Ca prostate with distant metastasis. In hematological parameter maximum patients (63.6%) were found to have normal haemogram.13.2% patients had anemia. In PSA evaluation, maximum (81.2%) patients were found to have within normal limits of PSA (1-5 ng/mL) followed by 10% had 6-10 ng/mL. 7.2% patients had 11-50 ng/mL and only 1.6% patients had PSA more than 50 ng/mL. Alkaline Phosphatase level was 1-5 IU/L in 82.4% patients followed by 16-30 IU/L in 13.2% cases, 31-45 IU/L in 2.8% cases and more than 45 IU/L in 1.6% of cases. Median PSA level in histopathologically proved cases of carcinoma prostate was found to 60.5% ng/mL in 4.44% of patients and according to gleason grade PSA level was the 40.9% ng/mL in 8.88% of cases.

Conclusion: The PSA test can detect high levels of PSA that may indicate the presence of prostate cancer. However, many other conditions, such as an enlarged or inflamed prostate, can also increase PSA levels. Therefore, determining what a high PSA score means can be complicated.

Keywords: PSA, BPH, Carcinoma, Histopathology, Serum Creatinine.

References

  1. Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. New England Journal of Medicine 2004;350(22):2239-2246.
  2. Barry MJ. Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer. New England Journal of Medicine 2001;344(18):1373-1377.
  3. Pinsky PF, Prorok PC, Yu K, et al. Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years. Cancer 2017; 123(4):592-599.
  4. Schröder FH, Hugosson J, Roobol MJ, et al. Prostate-cancer mortality at 11 years of follow-up. New England Journal of Medicine 2012;366(11):981-990.
  5. Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostate cancer mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 2014; 384: 2027-2035.
  6. Tsodikov A, Gulati R, Heijnsdijk EAM, et al. Reconciling the effects of screening on prostate cancer mortality in the ERSPC and PLCO trials. Atalas of Internal Medicine2017; 167(7):449-455.
  7. S. Preventive Health Services Task Force 2017. Accessed April 24, 2017.
  8. Klein EA, Chait A, Hafron JM, et al. The single-parameter, structure-based IsoPSA assay demonstrates improved diagnostic accuracy for detection of any prostate cancer and high-grade prostate cancer compared to a concentration-based assay of total prostate-specific antigen: A preliminary report. European Urology 2017; S0302-2838(17)30236-1.

Corresponding Author

Dr Satyendu Sagar

Department of Microbiology, Nalanda Medical College, Patna, India